Quo vadis polyplex?

Journal of Controlled Release

Volumn 190, Issue , 2014, Pages 415-423

  Merkel, Olivia M ^a,b   Kissel, Thomas ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Biodegradation; Biodistribution; Nanocarrier; Polymer; siRNA; Stability

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADATION; CONVERGENCE OF NUMERICAL METHODS; FUNCTIONAL POLYMERS; POLYMERS;

BIODISTRIBUTIONS; CLINICAL TRANSLATION; CONTROLLED RELEASE; ENDOSOMAL RELEASE; NANOCARRIERS; POLYMERIC CARRIERS; SIRNA; STABILITY ISSUES;

BIODEGRADABLE POLYMERS;

DRUG CARRIER; FC RECEPTOR; IMMUNOGLOBULIN G; MICROSPHERE; NANOCARRIER; NANOPARTICLE; NANOSPHERE; NOGGIN; NUCLEIC ACID; POLYCATION; POLYESTER; POLYETHYLENEIMINE; POLYGLACTIN; POLYMER; SMALL INTERFERING RNA; BIOMATERIAL; BEVACIZUMAB; CARMUSTINE; CLODRONIC ACID; COPPER 64; HYALURONIC ACID; NITROSOUREA; PARACETAMOL; PHOSPHORUS 32; POLYAMIDOAMINE; POLYLACTIC ACID; POLYPLEX; SPERMIDINE; STATHMIN; TETRAXETAN; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; BIODEGRADABILITY; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG STABILITY; DRUG TRANSPORT; ENDOSOME; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; IN VIVO STUDY; INTRACELLULAR TRANSPORT; NANOENCAPSULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMA CLEARANCE; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; SERUM; TEMPOROMANDIBULAR JOINT DISORDER; ANIMAL; BIOAVAILABILITY; HUMAN; PHARMACOKINETICS; AREA UNDER THE CURVE; COMPLEX FORMATION; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG RELEASE; ISOTOPE LABELING; POLYMERIZATION; RNA TRANSLATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL AVAILABILITY; DRUG CARRIERS; HUMANS; NANOPARTICLES; PHARMACOKINETICS; POLYMERS; RNA, SMALL INTERFERING;

EID: 84906784810     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.06.009     Document Type: Review

References (66)

1. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 1998 806 811 (Pubitemid 28099681)
2. M. Famulok, and S. Verma In vivo-applied functional RNAs as tools in proteomics and genomics research Trends Biotechnol. 20 2002 462 466 (Pubitemid 35292358)
3. M. Zheng, G.M. Pavan, M. Neeb, A.K. Schaper, A. Danani, G. Klebe, O.M. Merkel, and T. Kissel Targeting the blind spot of polycationic nanocarrier-based siRNA delivery ACS Nano 6 2012 9447 9454
4. C. Scholz, and E. Wagner Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers J. Control. Release 161 2012 554 565
5. M.E. Davis The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic Mol. Pharm. 6 2009 659 668
6. J. DeVincenzo, J.E. Cehelsky, R. Alvarez, S. Elbashir, J. Harborth, I. Toudjarska, L. Nechev, V. Murugaiah, A. Van Vliet, A.K. Vaishnaw, and R. Meyers Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV) Antiviral Res. 77 2008 225 231
7. J. DeVincenzo, R. Lambkin-Williams, T. Wilkinson, J. Cehelsky, S. Nochur, E. Walsh, R. Meyers, J. Gollob, and A. Vaishnaw A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus Proc. Natl. Acad. Sci. U. S. A. 107 2009 8800 8805
8. A. Santel, M. Aleku, O. Keil, J. Endruschat, V. Esche, G. Fisch, S. Dames, K. Loffler, M. Fechtner, W. Arnold, K. Giese, A. Klippel, and J. Kaufmann A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium Gene Ther. 13 2006 1222 1234 (Pubitemid 44184716)
9. D. Fischer, Y. Li, B. Ahlemeyer, J. Krieglstein, and T. Kissel In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis Biomaterials 24 2003 1121 1131 (Pubitemid 36069121)
10. S. Mao, M. Neu, O. Germershaus, O. Merkel, J. Sitterberg, U. Bakowsky, and T. Kissel Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft- poly(ethylene glycol) block copolymer/siRNA polyplexes Bioconjug. Chem. 17 2006 1209 1218 (Pubitemid 44455329)
11. O.M. Merkel, R. Urbanics, P. Bedocs, Z. Rozsnyay, L. Rosivall, M. Toth, T. Kissel, and J. Szebeni In vitro and in vivo complement activation and related anaphylactic effects associated with polyethylenimine and polyethylenimine- graft-poly(ethylene glycol) block copolymers Biomaterials 32 2011 4936 4942
12. A.S. Abu Lila, H. Kiwada, and T. Ishida The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage J. Control. Release 172 2013 38 47
13. A. Khan, M. Benboubetra, P.Z. Sayyed, K.W. Ng, S. Fox, G. Beck, I.F. Benter, and S. Akhtar Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies J. Drug Target. 12 2004 393 404 (Pubitemid 39302465)
14. J. Nguyen, T.W. Steele, O. Merkel, R. Reul, and T. Kissel Fast degrading polyesters as siRNA nano-carriers for pulmonary gene therapy J. Control. Release 132 2008 243 251
15. O.M. Merkel, and T. Kissel Nonviral pulmonary delivery of siRNA Acc. Chem. Res. 45 2012 961 970
16. P.M. Mountziaris, S.N. Tzouanas, D.C. Sing, P.R. Kramer, F.K. Kasper, and A.G. Mikos Intra-articular controlled release of anti-inflammatory siRNA with biodegradable polymer microparticles ameliorates temporomandibular joint inflammation Acta Biomater. 8 2012 3552 3560
17. G.B. Jacobson, E. Gonzalez-Gonzalez, R. Spitler, R. Shinde, D. Leake, R.L. Kaspar, C.H. Contag, and R.N. Zare Biodegradable nanoparticles with sustained release of functional siRNA in skin J. Pharm. Sci. 99 2010 4261 4266
18. Z.X. Zhao, S.Y. Gao, J.C. Wang, C.J. Chen, E.Y. Zhao, W.J. Hou, Q. Feng, L.Y. Gao, X.Y. Liu, L.R. Zhang, and Q. Zhang Self-assembly nanomicelles based on cationic mPEG-PLA-b-Polyarginine(R15) triblock copolymer for siRNA delivery Biomaterials 33 2012 6793 6807
19. T. Manaka, A. Suzuki, K. Takayama, Y. Imai, H. Nakamura, and K. Takaoka Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation Biomaterials 32 2012 9642 9648
20. X. Shuai, T. Merdan, F. Unger, and T. Kissel Supramolecular gene delivery vectors showing enhanced transgene expression and good biocompatibility Bioconjug. Chem. 16 2005 322 329 (Pubitemid 40388207)
21. M. Zheng, D. Librizzi, A. Kilic, Y. Liu, H. Renz, O.M. Merkel, and T. Kissel Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers Biomaterials 33 2012 6551 6558
22. T.K. Endres, M. Beck-Broichsitter, O. Samsonova, T. Renette, and T.H. Kissel Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery Biomaterials 32 2011 7721 7731
23. X.B. Xiong, H. Uludag, and A. Lavasanifar Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery Biomaterials 30 2009 242 253
24. T.M. Sun, J.Z. Du, Y.D. Yao, C.Q. Mao, S. Dou, S.Y. Huang, P.Z. Zhang, K.W. Leong, E.W. Song, and J. Wang Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression ACS Nano 5 2011 1483 1494
25. C.Q. Mao, J.Z. Du, T.M. Sun, Y.D. Yao, P.Z. Zhang, E.W. Song, and J. Wang A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy Biomaterials 32 2011 3124 3133
26. D. Lin, Q. Jiang, Q. Cheng, Y. Huang, P. Huang, S. Han, S. Guo, Z. Liang, and A. Dong Polycation-detachable nanoparticles self-assembled from mPEG-PCL-g-SS-PDMAEMA for in vitro and in vivo siRNA delivery Acta Biomater. 9 2013 7746 7757
27. C. Boyer, J. Teo, P. Phillips, R.B. Erlich, S. Sagnella, G. Sharbeen, T. Dwarte, H.T.T. Duong, D. Goldstein, T.P. Davis, M. Kavallaris, and J. McCarroll Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymers Mol. Pharm. 10 2013 2435 2444
28. J. Liu, Z. Jiang, S. Zhang, C. Liu, R.A. Gross, T.R. Kyriakides, and W.M. Saltzman Biodegradation, biocompatibility, and drug delivery in poly(omega-pentadecalactone-co-p-dioxanone) copolyesters Biomaterials 32 2011 6646 6654
29. Y. Wang, S. Gao, W.H. Ye, H.S. Yoon, and Y.Y. Yang Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer Nat. Mater. 5 2006 791 796 (Pubitemid 44570860)
30. S. Mao, W. Sun, and T. Kissel Chitosan-based formulations for delivery of DNA and siRNA Adv. Drug Deliv. Rev. 62 1 2010 12 27
31. W.E. Rudzinski, and T.M. Aminabhavi Chitosan as a carrier for targeted delivery of small interfering RNA Int. J. Pharm. 399 2010 1 11
32. T. Okuda, D. Kito, A. Oiwa, M. Fukushima, D. Hira, and H. Okamoto Gene silencing in a mouse lung metastasis model by an inhalable dry small interfering RNA powder prepared using the supercritical carbon dioxide technique Biol. Pharm. Bull. 36 2013 1183 1191
33. Y. Luo, X. Zhai, C. Ma, P. Sun, Z. Fu, W. Liu, and J. Xu An inhalable beta(2)-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung J. Control. Release 162 2012 28 36
34. Y. Obata, T. Nishino, T. Kushibiki, R. Tomoshige, Z. Xia, M. Miyazaki, K. Abe, T. Koji, Y. Tabata, and S. Kohno HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice Acta Biomater. 8 2012 2688 2696
35. H.Y. Yoon, H.R. Kim, G. Saravanakumar, R. Heo, S.Y. Chae, W. Um, K. Kim, I.C. Kwon, J.Y. Lee, D.S. Lee, J.C. Park, and J.H. Park Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting J. Control. Release 172 2013 653 661
36. A. San Juan, M. Bala, H. Hlawaty, P. Portes, R. Vranckx, L.J. Feldman, and D. Letourneur Development of a functionalized polymer for stent coating in the arterial delivery of small interfering RNA Biomacromolecules 10 2009 3074 3080
37. S. Khormaee, Y. Choi, M.J. Shen, B. Xu, H. Wu, G.L. Griffiths, R. Chen, N.K. Slater, and J.K. Park Endosomolytic anionic polymer for the cytoplasmic delivery of siRNAs in localized applications Adv. Funct. Mater. 23 2006
38. W. Xia, P. Wang, C. Lin, Z. Li, X. Gao, G. Wang, and X. Zhao Bioreducible polyethylenimine-delivered siRNA targeting human telomerase reverse transcriptase inhibits HepG2 cell growth in vitro and in vivo J. Control. Release 157 2012 427 436
39. H. Lim, J. Noh, Y. Kim, H. Kim, J. Kim, G. Khang, and D. Lee Acid-degradable cationic poly(ketal amidoamine) for enhanced RNA interference in vitro and in vivo Biomacromolecules 14 2013 240 247
40. D.A. Braasch, Z. Paroo, A. Constantinescu, G. Ren, O.K. Oz, R.P. Mason, and D.R. Corey Biodistribution of phosphodiester and phosphorothioate siRNA Bioorg. Med. Chem. Lett. 14 2004 1139 1143 (Pubitemid 38229843)
41. D.W. Bartlett, H. Su, I.J. Hildebrandt, W.A. Weber, and M.E. Davis Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging Proc. Natl. Acad. Sci. U. S. A. 104 2007 15549 15554 (Pubitemid 47502954)
42. O.M. Merkel, D. Librizzi, A. Pfestroff, T. Schurrat, M. Behe, and T. Kissel In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery using an optimized radiolabeling and purification procedure Bioconjug. Chem. 20 2009 174 182
43. O.M. Merkel, A. Beyerle, D. Librizzi, A. Pfestroff, T.M. Behr, B. Sproat, P.J. Barth, and T. Kissel Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance Mol. Pharm. 6 2009 1246 1260
44. O.M. Merkel, D. Librizzi, A. Pfestroff, T. Schurrat, K. Buyens, N.N. Sanders, S.C. De Smedt, M. Behe, and T. Kissel Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethylenimine)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging J. Control. Release 138 2009 148 159
45. O.M. Merkel, M.A. Mintzer, D. Librizzi, O. Samsonova, T. Dicke, B. Sproat, H. Garn, P.J. Barth, E.E. Simanek, and T. Kissel Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity Mol. Pharm. 7 2010 969 983
46. O.M. Merkel, M. Zheng, M.A. Mintzer, G.M. Pavan, D. Librizzi, M. Maly, H. Hoffken, A. Danani, E.E. Simanek, and T. Kissel Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems J. Control. Release 153 2011 23 33
47. B. Naeye, H. Deschout, V. Caveliers, B. Descamps, K. Braeckmans, C. Vanhove, J. Demeester, T. Lahoutte, S.C. De Smedt, and K. Raemdonck In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier Biomaterials 34 2012 2350 2358
48. T. Merdan, K. Kunath, H. Petersen, U. Bakowsky, K.H. Voigt, J. Kopecek, and T. Kissel PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice Bioconjug. Chem. 16 2005 785 792 (Pubitemid 41026164)
49. A. Malek, O. Merkel, L. Fink, F. Czubayko, T. Kissel, and A. Aigner In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes Toxicol. Appl. Pharmacol. 236 2009 97 108
50. G. Jiang, K. Park, J. Kim, K.S. Kim, and S.K. Hahn Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis Mol. Pharm. 6 2009 727 737
51. S. Hobel, A. Loos, D. Appelhans, S. Schwarz, J. Seidel, B. Voit, and A. Aigner Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): physicochemical and biological properties of DNA and siRNA complexes J. Control. Release 149 2011 146 158
52. S. Hobel, I. Koburger, M. John, F. Czubayko, P. Hadwiger, H.P. Vornlocher, and A. Aigner Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab J. Gene Med. 12 2010 287 300
53. A. Kano, K. Moriyama, T. Yamano, I. Nakamura, N. Shimada, and A. Maruyama Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA J. Control. Release 149 2011 2 7
54. S.Y. Duan, X.M. Ge, N. Lu, F. Wu, W. Yuan, and T. Jin Synthetic polyspermine imidazole-4, 5-amide as an efficient and cytotoxicity-free gene delivery system Int. J. Nanomedicine 7 2012 3813 3822
55. T. Asai, S. Matsushita, E. Kenjo, T. Tsuzuku, N. Yonenaga, H. Koide, K. Hatanaka, T. Dewa, M. Nango, N. Maeda, H. Kikuchi, and N. Oku Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery Bioconjug. Chem. 22 2011 429 435
56. D.A. Christian, O.B. Garbuzenko, T. Minko, and D.E. Discher Polymer vesicles with a red cell-like surface charge: microvascular imaging and in vivo tracking with near-infrared fluorescence Macromol. Rapid Commun. 31 2010 135 141
57. C.E. Nelson, J.R. Kintzing, A. Hanna, J.M. Shannon, M.K. Gupta, and C.L. Duvall Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo ACS Nano 7 2013 8870 8880
58. D.J. Gary, J. Min, Y. Kim, K. Park, and Y.Y. Won The effect of N/P ratio on the in vitro and in vivo interaction properties of PEGylated poly[2-(dimethylamino)ethyl methacrylate]-based siRNA complexes Macromol. Biosci. 13 2013 1059 1071
59. J. Zhang, C. He, C. Tang, and C. Yin Ternary polymeric nanoparticles for oral siRNA delivery Pharm. Res. 30 2013 1228 1239
60. J. Zhou, C.P. Neff, X. Liu, J. Zhang, H. Li, D.D. Smith, P. Swiderski, T. Aboellail, Y. Huang, Q. Du, Z. Liang, L. Peng, R. Akkina, and J.J. Rossi Systemic administration of combinatorial dsiRNAs via nanoparticles efficiently suppresses HIV-1 infection in humanized mice Mol. Ther. 19 2011 2228 2238
61. R.M. Schiffelers, A. Ansari, J. Xu, Q. Zhou, Q. Tang, G. Storm, G. Molema, P.Y. Lu, P.V. Scaria, and M.C. Woodle Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res. 32 2004 e149
62. K. Buyens, B. Lucas, K. Raemdonck, K. Braeckmans, J. Vercammen, J. Hendrix, Y. Engelborghs, S.C. De Smedt, and N.N. Sanders A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum J. Control. Release 126 2008 67 76
63. J.-P. Behr The proton sponge: a trick to enter cells the viruses did not exploit CHIMIA Int. J. Chem. 51 1997 34 36 (Pubitemid 127033737)
64. T. Merdan, K. Kunath, D. Fischer, J. Kopecek, and T. Kissel Intracellular processing of poly(ethylene imine)/ribozyme complexes can be observed in living cells by using confocal laser scanning microscopy and inhibitor experiments Pharm. Res. 19 2002 140 146 (Pubitemid 34165398)
65. A. El-Sayed, S. Futaki, and H. Harashima Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment AAPS J. 11 2009 13 22
66. S. Oliveira, I. van Rooy, O. Kranenburg, G. Storm, and R.M. Schiffelers Fusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenes Int. J. Pharm. 331 2007 211 214 (Pubitemid 46216677)